HSBC Holdings plc reiterated their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Wednesday morning. They currently have a GBX 1,970 ($25.44) price objective on the stock.

GSK has been the topic of a number of other reports. Shore Capital reissued a hold rating on shares of GlaxoSmithKline plc in a report on Friday, July 28th. Liberum Capital reissued a buy rating and issued a GBX 1,900 ($24.54) price objective on shares of GlaxoSmithKline plc in a report on Wednesday, August 30th. J P Morgan Chase & Co reissued a neutral rating on shares of GlaxoSmithKline plc in a report on Monday, July 24th. S&P Global set a GBX 1,500 ($19.37) price objective on GlaxoSmithKline plc and gave the company a sell rating in a report on Wednesday, July 26th. Finally, Credit Suisse Group cut their price objective on GlaxoSmithKline plc from GBX 1,775 ($22.92) to GBX 1,725 ($22.28) and set a neutral rating on the stock in a report on Wednesday, September 6th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and eight have assigned a buy rating to the company. GlaxoSmithKline plc has an average rating of Hold and an average price target of GBX 1,705.90 ($22.03).

GlaxoSmithKline plc (LON:GSK) traded down 0.70% on Wednesday, hitting GBX 1480.50. The stock had a trading volume of 8,162,653 shares. GlaxoSmithKline plc has a 12 month low of GBX 1,446.50 and a 12 month high of GBX 1,745.56. The company’s 50 day moving average is GBX 1,510.46 and its 200-day moving average is GBX 1,612.54. The stock’s market cap is GBX 72.37 billion.

WARNING: This piece was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at

The firm also recently announced a dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, August 10th will be paid a dividend of GBX 19 ($0.25) per share. The ex-dividend date of this dividend is Thursday, August 10th. This represents a yield of 1.23%.

In other news, insider Manvinder Singh Banga acquired 2,267 shares of the company’s stock in a transaction dated Wednesday, July 26th. The stock was acquired at an average cost of GBX 1,599 ($20.65) per share, with a total value of £36,249.33 ($46,815.61). Also, insider Victoria Whyte sold 4,820 shares of GlaxoSmithKline plc stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of GBX 1,693 ($21.86), for a total value of £81,602.60 ($105,388.87). In the last three months, insiders have acquired 3,152 shares of company stock valued at $5,055,023.

About GlaxoSmithKline plc

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with's FREE daily email newsletter.